Rhythm Biosciences Limited (ASX:RHY – Get Rating) insider Otto Buttula acquired 683,895 shares of the firm’s stock in a transaction that occurred on Friday, May 12th. The shares were bought at an average cost of A$0.36 ($0.24) per share, for a total transaction of A$248,253.89 ($166,613.35). Rhythm Biosciences Stock Performance The company has a quick […]
Brii Bio Publishes 2022 Environmental, Social and Governance Report streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Brii Biosciences Limited ("Brii Bio," "we," or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve.
Kimia Biosciences Limited has received the approval of Advance Authorisation License of Gliclazide BP an API from the office of the Additional Director General of Foreign Trade, CLA Delhi, under Directorate General of Foreign Trade.